ASX - By Stock
|
OCC |
Re:
Ann: Compelling 85% Success Rate Remplir Study now published
|
|
DaniJay
|
13 |
4.6K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
13
|
4.6K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Successful OrthoATI clinical trial
|
|
DaniJay
|
55 |
15K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
55
|
15K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Change of Director's Interest Notice-John Van Der Wielen
|
|
DaniJay
|
12 |
4.2K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
12
|
4.2K
|
8
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
DaniJay
|
72 |
22K |
19 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
72
|
22K
|
19
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
DaniJay
|
8 |
3.2K |
13 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
8
|
3.2K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
DaniJay
|
1.6K |
492K |
7 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
1.6K
|
492K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
DaniJay
|
550 |
173K |
11 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
550
|
173K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
DaniJay
|
1.6K |
492K |
6 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
1.6K
|
492K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
DaniJay
|
458 |
152K |
0 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
458
|
152K
|
0
|
|
ASX - By Stock
|
OCC |
Re:
Movement at the Station
|
|
DaniJay
|
71 |
22K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
71
|
22K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Remplir Nerve Repair - Distribution & Marketing
|
|
DaniJay
|
2 |
1.1K |
4 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
2
|
1.1K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Appendix 4C - Quarterly
|
|
DaniJay
|
8 |
2.5K |
6 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
8
|
2.5K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
DaniJay
|
46K |
11M |
1 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
46K
|
11M
|
1
|
|